Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Gallbladder Neoplasms 2Bile Duct Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Small Cell Lung Carcinoma 1Ovarian Neoplasms 1Liver Neoplasms 1Cholangiocarcinoma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1Biliary Tract Neoplasms 1

Interventions

Gemcitabine 8Fluorouracil 5Cisplatin 5Leucovorin 4Oxaliplatin 3becatecarin 2Capecitabine 2seribantumab 1sargramostim 1pembrolizumab 1pazopanib 1motexafin lutetium 1ixabepilone 1irinotecan sucrosofate 1incomplete Freund's adjuvant 1durvalumab 1devimistat 1cediranib 1Trastuzumab 1Sorafenib 1Radiosurgery 1Psychiatric Rehabilitation 1Palonosetron 1Observation 1Liver Transplantation 1Folfox protocol 1Escitalopram 1Erlotinib Hydrochloride 1Carboplatin 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Gallbladder Neoplasms × becatecarin × Clear all
NCT00005997 2010-06-11

Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer

Case Comprehensive Cancer Center

Phase 2 Terminated
72 enrolled
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

NCT00090025 2009-01-14

XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors

Helsinn Healthcare SA

Phase 3 Terminated
248 enrolled
Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡